A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 06 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 06 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.